Cardiovascular Systems Inc Quarterly Cost of Revenue in USD from Q3 2017 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Cardiovascular Systems Inc quarterly/annual Cost of Revenue history and growth rate from Q3 2017 to Q4 2022.
  • Cardiovascular Systems Inc Cost of Revenue for the quarter ending December 31, 2022 was $18.5M, a 2.15% increase year-over-year.
  • Cardiovascular Systems Inc Cost of Revenue for the twelve months ending December 31, 2022 was $66.2M, a 1.21% decline year-over-year.
  • Cardiovascular Systems Inc annual Cost of Revenue for 2022 was $63.4M, a 3.78% increase from 2021.
  • Cardiovascular Systems Inc annual Cost of Revenue for 2021 was $61.1M, a 25.4% increase from 2020.
  • Cardiovascular Systems Inc annual Cost of Revenue for 2020 was $48.8M, a 2.26% increase from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $66.2M $18.5M +$388K +2.15% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-09
Q3 2022 $65.8M $16.7M +$2.39M +16.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $63.4M $16.3M -$4.37M -21.2% Apr 1, 2022 Jun 30, 2022 10-K 2022-08-18
Q1 2022 $67.8M $14.8M +$777K +5.55% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $67M $18.1M +$4.15M +29.8% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-09
Q3 2021 $62.9M $14.3M +$1.74M +13.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $61.1M $20.6M +$10.5M +103% Apr 1, 2021 Jun 30, 2021 10-K 2022-08-18
Q1 2021 $50.6M $14M +$1.79M +14.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $48.9M $13.9M +$202K +1.47% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-03
Q3 2020 $48.7M $12.6M -$108K -0.85% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $48.8M $10.1M -$3.32M -24.6% Apr 1, 2020 Jun 30, 2020 10-K 2022-08-18
Q1 2020 $52.1M $12.2M +$59K +0.49% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $52M $13.7M +$2.24M +19.5% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 $49.8M $12.7M +$2.1M +19.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $47.7M $13.5M +$2.65M +24.5% Apr 1, 2019 Jun 30, 2019 10-K 2021-08-19
Q1 2019 $45M $12.2M +$2.2M +22% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $42.8M $11.5M +$1.98M +20.8% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 $40.9M $10.6M +$1.37M +14.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $39.5M $10.8M Apr 1, 2018 Jun 30, 2018 10-K 2020-08-20
Q1 2018 $9.97M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $9.5M Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-01
Q3 2017 $9.2M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.